These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9574935)

  • 21. Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.
    Kelly JM; Taylor MC; Horn D; Loza E; Kalvinsh I; Björkling F
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1886-90. PubMed ID: 22326398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of nucleotide sugar transport in Trypanosoma brucei alters surface glycosylation.
    Liu L; Xu YX; Caradonna KL; Kruzel EK; Burleigh BA; Bangs JD; Hirschberg CB
    J Biol Chem; 2013 Apr; 288(15):10599-615. PubMed ID: 23443657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides.
    Bacchi CJ; Sanabria K; Spiess AJ; Vargas M; Marasco CJ; Jimenez LM; Goldberg B; Sufrin JR
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2108-12. PubMed ID: 9333033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
    Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhancement of the trypanocidal activity of methyltriazenes in an animal model by the addition of an amidino group.
    Buddhu S; Penketh PG; Divo AA; Shyam K; Patton CL; Sartorelli AC
    Acta Trop; 1991 Apr; 49(1):69-72. PubMed ID: 1678578
    [No Abstract]   [Full Text] [Related]  

  • 27. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The trypanosome alternative oxidase: a potential drug target?
    Menzies SK; Tulloch LB; Florence GJ; Smith TK
    Parasitology; 2018 Feb; 145(2):175-183. PubMed ID: 27894362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folates in Trypanosoma brucei: Achievements and Opportunities.
    Cullia G; Tamborini L; Conti P; De Micheli C; Pinto A
    ChemMedChem; 2018 Oct; 13(20):2150-2158. PubMed ID: 30152195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbohydrate-binding agents act as potent trypanocidals that elicit modifications in VSG glycosylation and reduced virulence in Trypanosoma brucei.
    Castillo-Acosta VM; Vidal AE; Ruiz-Pérez LM; Van Damme EJ; Igarashi Y; Balzarini J; González-Pacanowska D
    Mol Microbiol; 2013 Nov; 90(4):665-79. PubMed ID: 23926900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel protein kinase is essential in bloodstream Trypanosoma brucei.
    Jensen BC; Booster N; Vidadala RS; Maly DJ; Parsons M
    Int J Parasitol; 2016 Jul; 46(8):479-83. PubMed ID: 27018127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
    Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
    Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel allosteric inhibitor of the uridine diphosphate N-acetylglucosamine pyrophosphorylase from Trypanosoma brucei.
    Urbaniak MD; Collie IT; Fang W; Aristotelous T; Eskilsson S; Raimi OG; Harrison J; Navratilova IH; Frearson JA; van Aalten DM; Ferguson MA
    ACS Chem Biol; 2013 Sep; 8(9):1981-7. PubMed ID: 23834437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
    Loiseau PM; Wolf JG; Gayral P
    Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugates of 2,4-Dihydroxybenzoate and Salicylhydroxamate and Lipocations Display Potent Antiparasite Effects by Efficiently Targeting the Trypanosoma brucei and Trypanosoma congolense Mitochondrion.
    Fueyo González FJ; Ebiloma GU; Izquierdo García C; Bruggeman V; Sánchez Villamañán JM; Donachie A; Balogun EO; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
    J Med Chem; 2017 Feb; 60(4):1509-1522. PubMed ID: 28112515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic dissection of drug resistance in trypanosomes.
    Alsford S; Kelly JM; Baker N; Horn D
    Parasitology; 2013 Oct; 140(12):1478-91. PubMed ID: 23552488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of selective tubulin inhibitors as potential anti-trypanosomal agents.
    Lama R; Sandhu R; Zhong B; Li B; Su B
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5508-16. PubMed ID: 22850214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif.
    Klee N; Wong PE; Baragaña B; Mazouni FE; Phillips MA; Barrett MP; Gilbert IH
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4364-6. PubMed ID: 20615694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trypanosome alternative oxidase as a target of chemotherapy.
    Nihei C; Fukai Y; Kita K
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):234-9. PubMed ID: 12084465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.